Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
Condition(s):MyelomaLast Updated:December 29, 2017Withdrawn
Hide Studies Not Open or Pending
Condition(s):MyelomaLast Updated:December 29, 2017Withdrawn
Condition(s):Superior Hypogastric Plexus Block; Hysterectomy; Pain, Postoperative; Gynecologic DiseaseLast Updated:March 13, 2024Completed
Condition(s):Shoulder PainLast Updated:April 14, 2015Completed
Condition(s):Dementia; Chronic Disease; Neoplasm Metastasis; Lung Neoplasm; Pulmonary Disease, Chronic Obstructive; Heart Failure,Congestive; Liver Cirrhosis; Kidney Failure, Chronic; Lung Diseases, Interstitial; Peripheral Vascular Disease; Diabetes With End Organ Injury; Palliative Care, Patient Care; Health Care Quality, Access, and Evaluation; Patient Care; Inpatients; Health Communication; Patient Care PlanningLast Updated:November 29, 2023Completed
Condition(s):Disorders of Consciousness; Severe Brain Injury; Post-comatose Non-communicative Patients; Vegetative State; Minimally Conscious StateLast Updated:May 3, 2021Completed
Condition(s):Family Caregiver; Dementia; Peer SupportLast Updated:October 11, 2023Enrolling by invitation
Condition(s):Keratoconus; Ectasia; DegenerationLast Updated:October 11, 2018Terminated
Condition(s):COVID; Drug Effect; Drug Interaction; Adverse Drug EventLast Updated:September 2, 2022Enrolling by invitation
Condition(s):Critical IllnessLast Updated:January 3, 2024Completed
Condition(s):AnesthesiaLast Updated:July 16, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.